Subcutaneous ocrelizumab in patients with multiple sclerosis: results of the phase III OCARINA II study
Year: 2024
Type: conference-paper
Study design: Clinical Trial
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404184043
